Karl Butterworth

Phone+44 (0)28 9097 2307
Emailk.butterworthqub.acuk

Room 02.009 - PGJCCR
United Kingdom

Accepting PhD Students

PhD projects

Dr Butterworth is open to wide-ranging PhD applications from candidates with a basic science or clinical background.
His fields of interest include:
-Radiation Biology, Radiation Oncology and Cancer Imaging.
-Nanomedicine.
-Preclinical models and small animal radiotherapy.

Previous research experience is desirable although not essential.

Research activity per year

4 Finished

4 results

Finished

R5051CNR: Physical and biological characterisation of clinically relevant combined MRI-radiation exposures with conventional and nanoparticle contrast agents
Prise, K. (PI) & Butterworth, K. (CoI)
27/09/2017 → 30/09/2020
Project: Research
R1709CNR: Physical and Biological characterisation of combined MRI radiation exposures with conventional and nanoparticle contrast agents.
Prise, K. (PI) & Butterworth, K. (CoI)
04/01/2017 → 30/09/2020
Project: Research
R2231CNR: Assessment of tumour efficacy and normal tissue toxicity using AZD6738 in combination with radiotherapy for non-small cell lung cancer
Hanna, G. (PI), Butterworth, K. (CoI) & Prise, K. (CoI)
01/10/2015 → 31/03/2017
Project: Research
R5885CNR: Investigation of radiobiological efficacy of cannabinol derivatives
Butterworth, K. (PI) & Prise, K. (CoI)
25/09/2015 → 29/02/2016
Project: Research

Karl Butterworth

Projects

Search results

R5051CNR: Physical and biological characterisation of clinically relevant combined MRI-radiation exposures with conventional and nanoparticle contrast agents

R1709CNR: Physical and Biological characterisation of combined MRI radiation exposures with conventional and nanoparticle contrast agents.

R2231CNR: Assessment of tumour efficacy and normal tissue toxicity using AZD6738 in combination with radiotherapy for non-small cell lung cancer

R5885CNR: Investigation of radiobiological efficacy of cannabinol derivatives